Background: To understand the impact and burden of disease experienced by patients with hereditary angioedema (HAE).
Objective: To determine whether the use of short message service (SMS) to communicate with patients with HAE facilitates the collection of attack rate, medication use, and quality of life measurements.
Methods: Patients aged 12 years and older with doctor-confirmed HAE C1-inhibitor deficiency types I and II were invited to participate.